Instil Bio Pulls Plug On Lead Drug Development
Bullish Outlook On Instil Bio's Investigational Cancer Drug: Jefferies Sees Over 300% Stock Upside
Crude Oil Surges Over 1%; Instil Bio Shares Plunge
Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance